Pierre-emmanuel E. Stoebner

Nimes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Journal: The oncologist

Published: October 15, 2025

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Keep the gauze in the box: A simple way to improve specimen preparation for the muffin micrographic surgery technique.

Keep the gauze in the box: A simple way to improve specimen preparation for the muffin micrographic surgery technique.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 22, 2024

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: July 17, 2024

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors.

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors.

Journal: Acta dermato-venereologica

Published: May 31, 2024

When to stop immunotherapy for advanced melanoma: the emulated target trials.

When to stop immunotherapy for advanced melanoma: the emulated target trials.

Journal: EClinicalMedicine

Published: January 31, 2024

Two cases of multiple onychomatricomas affecting the fingers on both hands.

Two cases of multiple onychomatricomas affecting the fingers on both hands.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 20, 2024

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.

Journal: The oncologist

Published: September 20, 2023

Using of a Foam Earplug: A Nose Surgery Pearl.

Using of a Foam Earplug: A Nose Surgery Pearl.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: April 03, 2023

Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.

Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.

Journal: JCO precision oncology

Published: November 10, 2022

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France.

Journal: Current oncology (Toronto, Ont.)

Published: October 19, 2022

Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.

Impact of systemic therapies in metastatic melanoma of unknown primary: A study from MELBASE, a French multicentric prospective cohort.

Journal: Journal of the American Academy of Dermatology

Published: September 01, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026